Who owns the ENHANCED BRAIN DELIVERY trademark?

The ENHANCED BRAIN DELIVERY trademark is owned by Acumen Pharmaceuticals, Inc..

What is the serial number for ENHANCED BRAIN DELIVERY?

The USPTO serial number for ENHANCED BRAIN DELIVERY is 99272511.

What is the registration number for ENHANCED BRAIN DELIVERY?

ENHANCED BRAIN DELIVERY is registered under USPTO registration number 0.

ENH

USPTO Trademark Record

PENDING

ENHANCED BRAIN DELIVERY

Q: What class is the ENHANCED BRAIN DELIVERY trademark registered in?

The ENHANCED BRAIN DELIVERY trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 99272511·Reg 0·Filed Jul 08, 2025

Owner Acumen Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

ENHANCED BRAIN DELIVERY (Serial No. 99272511), Registration No. 0, is a pending US trademark filed on Jul 08, 2025 by Acumen Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

ENHANCED BRAIN DELIVERY (Reg. #0) is a pending US trademark that was filed in 2025 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs....

FILED

Jul 08, 2025

SERIAL

99272511

REG#

REGISTERED

Dec 31, 1969

Owner

Applicant

Acumen Pharmaceuticals, Inc.

Entity

Corporation

State

Address

1210-1220 Washington Street, Suite 210, Newton, MA, 02465

Country

Attorney

NameJane Massey Licata

Law firm

Jane Massey Licata Licata & Tyrrell P.C.

Docket

API0030TM

Address

66 E. Main Street, Marlton, NJ 08053, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateJul 08, 2025

Serial Number99272511

Registration No.0

Registration DateDec 31, 1969

Status DateAug 04, 2026

Mark TypeStandard characters

Attorney DocketAPI0030TM

Status DescriptionLive and pending, report completed suspension check

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

—

Suspension deadline Nov 04, 2026

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

14 events

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Aug 04, 2026

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

SUSPENSION LETTER WRITTEN

Feb 04, 2026

SUSPENSION LETTER WRITTEN

LETTER OF SUSPENSION E-MAILED

Feb 04, 2026

LETTER OF SUSPENSION E-MAILED

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Feb 04, 2026

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 24, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 24, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 24, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Dec 08, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Dec 08, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 08, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Nov 25, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION ENTERED

Jul 08, 2025

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 08, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Jul 08, 2025

APPLICATION FILING RECEIPT MAILED

ENHANCED BRAIN DELIVERY

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Acumen Pharmaceuticals, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Jane Massey Licata

Resources

Company